Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, shares how his company’s long history in ophthalmology helps it pave a path for new markets and technologies.
00:34 – How much of Carl Zeiss is ophthalmology?
01:00 – In ophthalmology we try to provide everything needed for diagnosis and treatment.
01:30 – The three parts of Zeiss
01:55- How have you seen the ophthalmology sector change?
02:45 – Are you acquiring start-ups?
03:10 – It really starts with working with surgeons and ophthalmologists.
04:04 – How is the Legacy of Zeiss a help and a hindrance?
05:10 – Zeiss benefits from a really strong brand.
05:25 – What other areas of ophthalmology will you target?
06:39 – How do Zeiss European roots help?
Ludwin Monz, PhD
Dr. Ludwin Monz has been President and CEO of Carl Zeiss Meditec AG since 2010 and was appointed a member of the Executive Board of the ZEISS group in 2014. Carl Zeiss Meditec is the medical technology company of the ZEISS group.